Porphyria cutanea tarda and pregnancy

Porphyria cutanea tarda is the most common disorder of porphyrin metabolism in Europe and North America. The disorder is characterized by specific cutaneous lesions, associated systemic findings, and excessive accumulation and excretion of uroporphyrin and coproporphyrins. Reports of this condition...

Full description

Saved in:
Bibliographic Details
Published inObstetrical & gynecological survey Vol. 51; no. 8; p. 493
Main Authors Loret de Mola, J R, Muise, K L, Duchon, M A
Format Journal Article
LanguageEnglish
Published United States 01.08.1996
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Porphyria cutanea tarda is the most common disorder of porphyrin metabolism in Europe and North America. The disorder is characterized by specific cutaneous lesions, associated systemic findings, and excessive accumulation and excretion of uroporphyrin and coproporphyrins. Reports of this condition associated with pregnancy are scarce in the literature. In this review, we present the case of a patient with porphyria cutanea tarda to illustrate the natural progression and complications of the disorder during pregnancy. Based in this report and a review of the published cases, pregnancy may exacerbate the cutaneous lesions of porphyria cutanea tarda during the first trimester. The incidence of diabetes, antinuclear antibodies, and hepatitis B and C are increased among them, making glucose tolerance and antibody testing mandatory. Newborns should be tested for the disorder during the neonatal period. Genetic counseling is advisable as well as teaching avoidance of provocative factors in affected children.
ISSN:0029-7828
DOI:10.1097/00006254-199608000-00022